{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T10:43:09Z","timestamp":1773312189450,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.steroids.2018.04.006","type":"journal-article","created":{"date-parts":[[2018,4,22]],"date-time":"2018-04-22T21:48:01Z","timestamp":1524433681000},"page":"31-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Urinary steroid profiling by gas chromatography mass spectrometry: Early features of malignancy in patients with adrenal incidentalomas"],"prefix":"10.1016","volume":"135","author":[{"given":"Z.R.","family":"Shafigullina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.I.","family":"Velikanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.V.","family":"Vorokhobina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.B.","family":"Shustov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.A.","family":"Lisitsin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.V.","family":"Malevanaia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.O.","family":"Buinova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.A.","family":"Bessonova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.O.","family":"Kirsanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3\u20135","key":"10.1016\/j.steroids.2018.04.006_b0005","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jsbmb.2010.04.010","article-title":"Gas chromatography\/mass spectrometry (GC\/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC\/MS\/MS)","volume":"121","author":"Krone","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"8","key":"10.1016\/j.steroids.2018.04.006_b0010","article-title":"Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism","volume":"2","author":"Arlt","year":"2017","journal-title":"J. Clin. Invest. Insight"},{"key":"10.1016\/j.steroids.2018.04.006_b0015","doi-asserted-by":"crossref","unstructured":"L.I. Velikanova, Z.R. Shafigullina, N.V. Vorokhobina, K. Grigoryan, A.A. Lisitsin, E.V. Obedkova, Differential diagnostics of adrenocortical incidentalomas with different laboratory technologies. Herald of the Northwestern State Medical University named after I.I. Mechnikov. 7 (4) (2015):52\u201357 (in Russ).","DOI":"10.17816\/mechnikov20157452-57"},{"issue":"2","key":"10.1016\/j.steroids.2018.04.006_b0020","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1530\/EJE-16-0461","article-title":"Management of endocrine disease: imaging for the diagnosis of malignancy in incidentally discovered adrenal masses: a systematic review and metaanalysis","volume":"175","author":"Dinnes","year":"2016","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.steroids.2018.04.006_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur. J. Endocrinol."},{"issue":"12","key":"10.1016\/j.steroids.2018.04.006_b0030","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1210\/jc.2011-1565","article-title":"Urine steroid metabolomics as biomarker tool for detecting malignancy in adrenal tumors","volume":"96","author":"Arlt","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.steroids.2018.04.006_b0035","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s12672-015-0224-3","article-title":"Diagnostic value of urinary steroid profiling in the evaluation of adrenal tumors","volume":"6","author":"Kerkhofs","year":"2015","journal-title":"Hormones Cancer"},{"issue":"5\u20136","key":"10.1016\/j.steroids.2018.04.006_b0040","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s12672-016-0267-0","article-title":"Different types of urinary steroid profiling obtained by high-performance liquid chromatography and gas chromatography-mass spectrometry in patients with adrenocortical carcinoma","volume":"7","author":"Velikanova","year":"2016","journal-title":"Hormones Cancer"},{"issue":"4","key":"10.1016\/j.steroids.2018.04.006_b0045","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1530\/EJE-09-0234","article-title":"Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink?","volume":"161","author":"Cawood","year":"2009","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"10.1016\/j.steroids.2018.04.006_b0050","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2214\/AJR.07.2799","article-title":"The incidental adrenal mass on ct: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy","volume":"190","author":"Song","year":"2009","journal-title":"Am. J. Roentgenol."},{"issue":"6","key":"10.1016\/j.steroids.2018.04.006_b0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1530\/EJE-17-0037","article-title":"From benign adrenal incidentaloma to adrenocortical carcinoma: an exceptional random event","volume":"176","author":"Belmihoub","year":"2017","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.steroids.2018.04.006_b0060","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12020-015-0694-7","article-title":"Preexisting adrenal masses in patients with adrenocortical carcinoma: clinical and radiological factors contributing to delayed diagnosis","volume":"51","author":"Ozsari","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.steroids.2018.04.006_b0065","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1530\/EJE-14-0113","article-title":"Therapy of endocrine disease: treatment of malignant pheochromocytoma and paraganglioma","volume":"3","author":"Baudin","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.steroids.2018.04.006_b0070","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1530\/ERC-15-0175","article-title":"15 years of paraganglioma: imaging and imaging-based treatment of pheochromocytoma and paraganglioma","volume":"4","author":"Castinetti","year":"2015","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.steroids.2018.04.006_b0075","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1210\/jc.2009-1248","article-title":"Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma","volume":"12","author":"Timmers","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.steroids.2018.04.006_b0080","first-page":"122","article-title":"Comparison of metaiodobenzylguanidine scintigraphy with positron emission tomography in the diagnostic work-up of pheochromocytoma and paraganglioma: a systematic review","volume":"2","author":"Rufini","year":"2013","journal-title":"Q. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.steroids.2018.04.006_b0085","first-page":"198","article-title":"Distinction between benign and malignant pheochromocytomas","volume":"3","author":"Liu","year":"2004","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"7","key":"10.1016\/j.steroids.2018.04.006_b0090","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1134\/S1061934816070169","article-title":"Generation of urinary steroid profiles in patients with adrenal incidentaloma using gas chromatography\u2013mass spectrometry","volume":"71","author":"Velikanova","year":"2016","journal-title":"J. Anal. Chem."},{"key":"10.1016\/j.steroids.2018.04.006_b0095","series-title":"Chemometrics. Data Analysis for the Laboratory and Chemical Plant","author":"Brereton","year":"2003"},{"issue":"6","key":"10.1016\/j.steroids.2018.04.006_b0100","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/BF03347480","article-title":"Does tumor heterogeneity limit the use of the Weiss criteria in the evaluation of adrenocortical tumors?","volume":"27","author":"Pohlink","year":"2004","journal-title":"J. Endocrinol. Invest."},{"issue":"4","key":"10.1016\/j.steroids.2018.04.006_b0105","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s12672-015-0225-2","article-title":"Radiographic characteristics of adrenal masses preceding the diagnosis of adrenocortical cancer","volume":"6","author":"Nogueira","year":"2015","journal-title":"Hormones Cancer"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X18300758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X18300758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T20:32:52Z","timestamp":1571257972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X18300758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":21,"alternative-id":["S0039128X18300758"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2018.04.006","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary steroid profiling by gas chromatography mass spectrometry: Early features of malignancy in patients with adrenal incidentalomas","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2018.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}